Fang X et al. |
[Inhibitory activity of azithromycin on biofilm synthesis and synergism between azithromycin and fleroxacin on Pseudomonas aeruginosa in biofilms]. |
1998 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:11360505
|
Palomar R et al. |
Effectiveness and safety of azithromycin on the treatment of cyclosporine-induced gingival overgrowth. |
1998 |
Nephron |
pmid:9609470
|
Matlow A et al. |
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593171
|
Kozyrskyj AL et al. |
Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. |
1998 |
JAMA |
pmid:9624028
|
Nowicki M et al. |
Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report. |
1998 |
Ann. Transplant. |
pmid:10234432
|
Karcioglu ZA et al. |
Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels. |
1998 |
Ophthalmology |
pmid:9544640
|
Edelstein PH |
Legionnaires' disease. |
1998 |
N. Engl. J. Med. |
pmid:9441231
|
Hillis SD et al. |
Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. |
1998 |
Sex Transm Dis |
pmid:9437777
|
Andersen SL et al. |
Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. |
1998 |
Clin. Infect. Dis. |
pmid:9455524
|
Chia JK et al. |
Azithromycin for the treatment of cat-scratch disease. |
1998 |
Clin. Infect. Dis. |
pmid:9455538
|
Peterson J and Treadway G |
Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. |
1998 |
Clin. Infect. Dis. |
pmid:9455579
|
Holmberg SD et al. |
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. |
1998 |
JAMA |
pmid:9459473
|
Rajyaguru JM and Muszynski MJ |
Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. |
1998 |
J. Antimicrob. Chemother. |
pmid:9533472
|
Varvara G and D'Arcangelo C |
[The evaluation of the clinical efficacy and tolerance of azithromycin in odontostomatological infections]. |
1998 Jan-Feb |
Minerva Stomatol |
pmid:9578649
|
Kalenić S et al. |
Helicobacter pylori: in vitro induction of resistance to azithromycin. |
1998 Jan-Feb |
Chemotherapy |
pmid:9444404
|
Russell TS et al. |
Eradication of Cryptosporidium in a child undergoing maintenance chemotherapy for leukemia using high dose azithromycin therapy. |
1998 Jan-Feb |
J. Pediatr. Hematol. Oncol. |
pmid:9482419
|
Rapp RP |
Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. |
1998 Jul-Aug |
Ann Pharmacother |
pmid:9681095
|
Zaremba CD |
Comment: could acetaminophen have played a role in a possible azithromycin-warfarin interaction? |
1998 Jul-Aug |
Ann Pharmacother |
pmid:9681108
|
Dohmen W and Seelis RE |
The role of azithromycin in the treatment of Helicobacter pylori infection - a retrospective report. |
1998 Jul-Aug |
Infection |
pmid:9867486
|
Diculencu D et al. |
[The postantibiotic effect of azithromycin on respiratory pathogens]. |
1998 Jul-Dec |
Rev Med Chir Soc Med Nat Iasi |
pmid:10756861
|
Shafran SD |
Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. |
1998 Jul-Sep |
Int. J. Infect. Dis. |
pmid:9831675
|
Venuta A et al. |
Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. |
1998 Jun-Jul |
J. Int. Med. Res. |
pmid:9718470
|
|
LaCARP opens clinical trials to patients of all primary care providers. |
1998 Mar-Apr |
Fac Notes (New Orleans La) |
pmid:11365129
|
Chakrabarti MK et al. |
Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. |
1998 Mar-Apr |
Chemotherapy |
pmid:9551241
|
Clement PA and de Gandt JB |
A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults. |
1998 Mar-Apr |
J. Int. Med. Res. |
pmid:9602984
|
Schuster FL and Visvesvara GS |
Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas. |
1998 Nov-Dec |
J. Eukaryot. Microbiol. |
pmid:9864851
|
Bonoan JT et al. |
Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone. |
1998 Nov-Dec |
Heart Lung |
pmid:9835673
|
Adriaenssen CF |
Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses. |
1998 Oct-Nov |
J. Int. Med. Res. |
pmid:9924711
|
Montenez JP et al. |
Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. |
1999 |
Toxicol. Appl. Pharmacol. |
pmid:10198278
|
Amsden GW |
Pharmacological considerations in the emergence of resistance. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204634
|
Retsema JA |
Susceptibility and resistance emergence studies with macrolides. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204635
|
Wubbel L et al. |
Etiology and treatment of community-acquired pneumonia in ambulatory children. |
1999 |
Pediatr. Infect. Dis. J. |
pmid:10048679
|
Eagan L |
Data on HIV infection in women expands. |
1999 |
Posit Living |
pmid:11367336
|
Wyrick PB et al. |
Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. |
1999 |
J. Infect. Dis. |
pmid:10068592
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Anderson JL et al. |
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. |
1999 |
Circulation |
pmid:10096928
|
Howard KB et al. |
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. |
1999 |
Am J Health Syst Pharm |
pmid:10478989
|
Taylor WR et al. |
Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. |
1999 |
Clin. Infect. Dis. |
pmid:10028075
|
Shanks GD |
Possible options for malaria chemoprophylaxis on the horizon. |
1999 |
J Travel Med |
pmid:23573551
|
Mabey D and Bailey R |
Eradication of trachoma worldwide. |
1999 |
Br J Ophthalmol |
pmid:10535853
|
Muhlestein JB |
Animal models of chlamydia and atherosclerosis. |
1999 |
Am. Heart J. |
pmid:10539862
|
Gupta S |
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease. |
1999 |
Am. Heart J. |
pmid:10539869
|
Dunne M |
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. |
1999 |
Am. Heart J. |
pmid:10539870
|
Grayston JT |
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis. |
1999 |
Am. Heart J. |
pmid:10539875
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Schachter J et al. |
Azithromycin in control of trachoma. |
1999 |
Lancet |
pmid:10466664
|
Chern KC et al. |
Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. |
1999 |
Br J Ophthalmol |
pmid:10574809
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Koletar SL et al. |
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582873
|
Dunne MW et al. |
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group. |
1999 |
Lancet |
pmid:10489947
|
Nicolau DP et al. |
Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582906
|
Blandizzi C et al. |
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. |
1999 |
J. Periodontol. |
pmid:10505797
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Jackson LA et al. |
Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease. |
1999 |
J. Antimicrob. Chemother. |
pmid:10511413
|
Ghaffar F et al. |
Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. |
1999 |
J. Pediatr. |
pmid:10547251
|
Fong IW et al. |
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548582
|
|
[Short-term therapy with Azithromycin. Pneumonia-pathogens, most commonly encountered in practice, easily targeted]. |
1999 |
Internist (Berl) |
pmid:10549000
|
Foulds G et al. |
The effect of azithromycin on the pharmacokinetics of indinavir. |
1999 |
J Clin Pharmacol |
pmid:10434237
|
Umut S et al. |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group. |
1999 |
J Chemother |
pmid:10435684
|
Krichhoff RM et al. |
Determination of azithromycin in gastric biopsy samples. |
1999 |
Int J Clin Pharmacol Ther |
pmid:10442511
|
Kamath R |
Antibiotic therapy for Salmonella enteritis. |
1999 |
J Paediatr Child Health |
pmid:10457286
|
Chiu CH et al. |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children. |
1999 |
J Paediatr Child Health |
pmid:10457295
|
Grimes DA and Schulz KF |
Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. |
1999 |
Contraception |
pmid:10592851
|
Ouchi K |
Chlamydia pneumoniae and atherosclerosis. |
1999 |
Jpn. J. Infect. Dis. |
pmid:10738358
|
Oliva S et al. |
Successful treatment of widely disseminated acanthamoebiasis. |
1999 |
South. Med. J. |
pmid:9932828
|
Ghirga G et al. |
Inefficacy of a 3-day course of azithromycin in preventing acute rheumatic fever after group A streptococcal infection (scarlet fever) in an 8-year-old child. |
1999 |
J. Pediatr. |
pmid:9880464
|
Karcioglu ZA et al. |
Pharmacokinetics of azithromycinin rabbit lacrimal glands and conjunctiv a. |
1999 |
Ophthalmic Res. |
pmid:9831822
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Wirnsberger GH et al. |
Chronic bacterial inflammation of the gum: the main risk factor for posttransplant gingival hyperplasia? |
1999 |
Clin. Nephrol. |
pmid:9988152
|
Cazzola M et al. |
Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. |
1999 |
J Chemother |
pmid:10326742
|
Preheim LC et al. |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. |
1999 |
Alcohol. Clin. Exp. Res. |
pmid:10371404
|
|
Drugs for sexually transmitted infections. |
1999 |
Med Lett Drugs Ther |
pmid:10906932
|
Alvarez-Elcoro S and Enzler MJ |
The macrolides: erythromycin, clarithromycin, and azithromycin. |
1999 |
Mayo Clin. Proc. |
pmid:10377939
|
Scharfstein JA et al. |
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. |
1999 |
Int J Technol Assess Health Care |
pmid:10874380
|
Principi N and Esposito S |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. |
1999 |
Drug Saf |
pmid:9935275
|
Alvarez Gutiérrez FJ et al. |
[A randomized comparative study of 3 days of azithromycin treatment and 10 days of cefuroxime treatment in exacerbations in patients with chronic obstructive pulmonary disease]. |
1999 |
Med Clin (Barc) |
pmid:10472596
|
Amsden GW et al. |
Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869584
|
Breitschwerdt EB et al. |
Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103185
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Taylor KI and Taylor HR |
Distribution of azithromycin for the treatment of trachoma. |
1999 |
Br J Ophthalmol |
pmid:10396186
|
Vcev A et al. |
High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers. |
1999 |
Helicobacter |
pmid:10352088
|
Cinti S et al. |
Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor. |
1999 |
J. Infect. Dis. |
pmid:10353887
|
Lombardo L et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379493
|
Moore PA |
Dental therapeutic indications for the newer long-acting macrolide antibiotics. |
1999 |
J Am Dent Assoc |
pmid:10492541
|
Trautmann M et al. |
Combined activity of azithromycin and lansoprazole against Helicobacter pylori. |
1999 |
Helicobacter |
pmid:10382125
|
de Vries PI et al. |
Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. |
1999 |
Trop. Med. Int. Health |
pmid:10402979
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
Donati M et al. |
Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. |
1999 |
J. Antimicrob. Chemother. |
pmid:10404322
|
Neiger R et al. |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii. |
1999 |
Am. J. Vet. Res. |
pmid:10407483
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|
Taylor H |
Towards the global elimination of trachoma. |
1999 |
Nat. Med. |
pmid:10229224
|
Lietman T et al. |
Global elimination of trachoma: how frequently should we administer mass chemotherapy? |
1999 |
Nat. Med. |
pmid:10229236
|